PLEASANTON, Calif., June 6, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.
On Thursday, June 9, the company will participate in the Goldman Sachs 32nd Annual Global Healthcare Conference. Gary F. Burbach, president and chief executive officer, will provide an update on the company beginning at 9:20 a.m., Pacific Daylight Time (12:20 p.m., Eastern Daylight Time). The presentation will be available through the conference web site at http://cc.talkpoint.com/gold006/060711a_lr/?entity=72_MUBESP4, or on the company's web site at http://www.thoratec.com.
On Wednesday, June 22, Thoratec will present at the 2011 Wells Fargo Securities Healthcare Conference. The presentation by Gary F. Burbach will begin at 1 p.m., Eastern Daylight Time (10 a.m., Pacific Daylight Time) and can be accessed through the conference web site at http://cc.talkpoint.com/well001/062211a_cy/?entity=1_XT1GIM0, or on the company's web site at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation.
|SOURCE Thoratec Corporation|
Copyright©2010 PR Newswire.
All rights reserved